- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis; Bone mineral density (BMD)
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Risedronate sodium – March 2013
Risedronate sodium, tablets, 5mg Actonel®
Last updated
8 November 2023
